• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to eliminate HCV in people who inject drugs in the USA.

作者信息

Dahari Harel, Boodram Basmattee

机构信息

Program for Experimental & Theoretical Modeling, Division of Hepatology, Loyola University Medical Center, Maywood, IL 60153, USA.

Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA.

出版信息

Lancet Infect Dis. 2018 Feb;18(2):134-135. doi: 10.1016/S1473-3099(17)30678-3. Epub 2017 Nov 15.

DOI:10.1016/S1473-3099(17)30678-3
PMID:29153267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5951630/
Abstract
摘要

相似文献

1
How to eliminate HCV in people who inject drugs in the USA.如何在美国消除注射吸毒者中的丙型肝炎病毒。
Lancet Infect Dis. 2018 Feb;18(2):134-135. doi: 10.1016/S1473-3099(17)30678-3. Epub 2017 Nov 15.
2
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.美国扩大的注射吸毒者网络中丙型肝炎病毒治疗作为预防措施：一项建模研究。
Lancet Infect Dis. 2018 Feb;18(2):215-224. doi: 10.1016/S1473-3099(17)30676-X. Epub 2017 Nov 15.
3
Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses.在注射毒品者中优先进行治疗以消除丙型肝炎：通过合理的经济分析解决抵触情绪。
Gut. 2017 Dec;66(12):2052-2053. doi: 10.1136/gutjnl-2016-312636. Epub 2016 Aug 26.
4
Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.综述文章：治疗即预防 - 将注射毒品者作为消除丙型肝炎的途径。
Aliment Pharmacol Ther. 2016 Jul;44(2):145-56. doi: 10.1111/apt.13673. Epub 2016 May 20.
5
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014 : a cross-sectional study.2011年至2014年比利时物质使用障碍治疗人群的丙型肝炎诊断检测：一项横断面研究。
Acta Gastroenterol Belg. 2019 Jan-Mar;82(1):35-42.
6
Commentary on Mahmud et al. (2020): Hepatitis C elimination efforts need to include people who inject drugs in the Middle East and North Africa.
Addiction. 2020 Jul;115(7):1263-1264. doi: 10.1111/add.15046. Epub 2020 Apr 15.
7
Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.短期和偶发性的注射中断与丙型肝炎病毒感染事件的相关性：来自加拿大蒙特利尔注射吸毒者队列研究的发现。
Addiction. 2019 Aug;114(8):1495-1503. doi: 10.1111/add.14632. Epub 2019 May 28.
8
Hepatitis C virus treatment as prevention in people who inject drugs.丙型肝炎病毒治疗作为对注射吸毒者的预防措施。
Lancet Infect Dis. 2018 Apr;18(4):379. doi: 10.1016/S1473-3099(18)30130-0. Epub 2018 Mar 21.
9
Time to end treatment restrictions for people with hepatitis C who inject drugs.是时候结束对注射毒品的丙型肝炎患者的治疗限制了。
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):142-143. doi: 10.1016/S2468-1253(18)30001-3. Epub 2018 Jan 6.
10
Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.2016年欧洲肝脏研究学会（EASL）丙型肝炎治疗建议中针对注射吸毒者的相互矛盾的建议。
J Hepatol. 2017 May;66(5):1101-1103. doi: 10.1016/j.jhep.2016.12.028. Epub 2017 Feb 3.

引用本文的文献

1
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.在芝加哥大都市地区，使用直接作用抗病毒药物对注射吸毒者进行丙型肝炎微消除建模。
PLoS One. 2022 Mar 10;17(3):e0264983. doi: 10.1371/journal.pone.0264983. eCollection 2022.
2
People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination.在芝加哥大都市地区注射毒品的人：1997-2017 年数据的荟萃分析，为丙型肝炎微消除的干预措施和计算模型提供信息。
PLoS One. 2022 Jan 12;17(1):e0248850. doi: 10.1371/journal.pone.0248850. eCollection 2022.
3
Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.2014 - 2017年美国医疗保险患者中丙型肝炎直接抗病毒药物使用方面城乡差距的变化
Am J Prev Med. 2021 Feb;60(2):285-293. doi: 10.1016/j.amepre.2020.08.031. Epub 2020 Nov 19.
4
MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS.基于吸毒人群主体模型的丙型肝炎消除多目标模型探索
Proc Winter Simul Conf. 2019 Dec;2019:1008-1019. doi: 10.1109/wsc40007.2019.9004747. Epub 2020 Feb 20.
5
Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.建模表明，在芝加哥大都市地区，针对注射毒品人群的高效疫苗干预措施可消除丙型肝炎病毒。
Vaccine. 2019 May 1;37(19):2608-2616. doi: 10.1016/j.vaccine.2019.02.081. Epub 2019 Apr 5.
6
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.患者病毒滴度模型表明，疫苗的可及性可以降低注射吸毒者中丙型肝炎病毒的传播。
Sci Transl Med. 2018 Jul 11;10(449). doi: 10.1126/scitranslmed.aao4496.
7
Federal Response to the Opioid Crisis.应对阿片类药物危机的联邦对策。
Curr HIV/AIDS Rep. 2018 Aug;15(4):293-301. doi: 10.1007/s11904-018-0398-8.

本文引用的文献

1
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.美国扩大的注射吸毒者网络中丙型肝炎病毒治疗作为预防措施：一项建模研究。
Lancet Infect Dis. 2018 Feb;18(2):215-224. doi: 10.1016/S1473-3099(17)30676-X. Epub 2017 Nov 15.
2
High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.高危地域流动模式：城市和城郊年轻吸毒者及其注射网络成员。
J Urban Health. 2018 Feb;95(1):71-82. doi: 10.1007/s11524-017-0185-7.
3
Direct-acting antivirals for acute HCV: how short can we go?用于急性丙型肝炎的直接作用抗病毒药物：我们能缩短到多短的疗程？
Lancet Gastroenterol Hepatol. 2017 May;2(5):316-318. doi: 10.1016/S2468-1253(17)30043-2. Epub 2017 Feb 28.
4
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir.丙型肝炎病毒动力学和模型分析表明，在索非布韦与达卡他韦、西米普韦或来迪帕司韦的联合治疗方案中，达到治愈的时间相似。
J Hepatol. 2016 Jun;64(6):1232-9. doi: 10.1016/j.jhep.2016.02.022. Epub 2016 Feb 22.
5
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.强化筛查与治疗对美国丙型肝炎的影响。
Clin Infect Dis. 2016 Feb 1;62(3):298-304. doi: 10.1093/cid/civ894. Epub 2015 Nov 30.
6
Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.芝加哥大都市地区注射吸毒者中扩大抗病毒治疗以降低丙型肝炎流行率的数学模型
PLoS One. 2015 Aug 21;10(8):e0135901. doi: 10.1371/journal.pone.0135901. eCollection 2015.
7
Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.2006 - 2012年，肯塔基州、田纳西州、弗吉尼亚州和西弗吉尼亚州30岁及以下人群中与注射吸毒相关的丙型肝炎病毒感染增加情况。
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8.
8
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.注网对吸毒人群丙型肝炎传播和治疗的影响。
Hepatology. 2014 Dec;60(6):1861-70. doi: 10.1002/hep.27403. Epub 2014 Oct 24.
9
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.2006-2012 年美国非城市地区年轻静脉注射吸毒者中丙型肝炎病毒感染的新出现流行。
Clin Infect Dis. 2014 Nov 15;59(10):1411-9. doi: 10.1093/cid/ciu643. Epub 2014 Aug 11.
10
Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.巴尔的摩和芝加哥大都市地区青年注射吸毒者中丙型肝炎病毒流行感染的社会行为和地理相关因素。
Drug Alcohol Depend. 2010 Sep 1;111(1-2):136-45. doi: 10.1016/j.drugalcdep.2010.04.003. Epub 2010 May 15.